Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
morphology of streptococci?
|
Gm(+) cocci in pairs or chains
|
|
growth conditions of strep?
|
strictly fermentative; catalase(-)
|
|
what is major cause of neonatal meningitis?
|
GBS
|
|
what is major virulence factor of GAS?
|
M protein
|
|
what exotoxins does GAS have?
|
cytolytic toxins and pyrogenic exotoxins
|
|
what ages is GAS typically found?
|
5-15 yrs
|
|
what acute respiratory infections are seen with GAS?
|
pharyngitis, scarlet fever (local infection with systemic toxemia), pneumonia
|
|
what is characteristic of scarlet fever?
|
begin on trunk and neck and spreading; blanches on pressure
|
|
sequelae of GAS?
|
ARF, AGN, PANDAS
|
|
morphology of corynebacterium?
|
Gm(+) pleomorphic rods
|
|
what are clinical manifestations of classical diphtheria?
|
local infection with systemic toxemia --> pharygitis, pseudomembrane, neck edema, with systemic toxemia may see necrosis in heart muscle and other tissue
|
|
what is vaccine for corynebacterium diphtheriae?
|
toxoid of diphtheria (DTaP, Tdap)
|
|
morphology of haemophilus?
|
tiny Gm(-) coccobacilli
|
|
growth requirements for h. influenzae?
|
X factor and V factor with chocolate agar
|
|
major virulence factor for h. influenzae and which type is most virulent?
|
capsule; type b
|
|
what was the most common cause of meningitis prior to vaccine?
|
h. influenzae
|
|
P1 protein is characteristic of what organism?
|
mycoplasma
|
|
what are clinical manifestations of mycoplasma infection?
|
pharyngitis, tracheobronchitis, ear pain, atypical pneumonia
|
|
what is typical to see in serology with mycoplasma?
|
cold agglutinins
|
|
what antibiotic for mycoplasma?
|
erythromycin
|
|
what is the most common cause of all fungal infections?
|
candida
|
|
what infections are seen with candida?
|
thrush, skin and nail infections, chronic mucocutaneous candidiasis, urotenital infections, gastrointestinal infections (assoc. with neoplastic disease of GI), invasive infection
|
|
morphology of bordetella?
|
Gm(-) coccobacilli
|
|
what disease is caused by bordetella?
|
pertussis, whooping cough
|
|
what organism has F-HA (fimbrial hemagglutinin)?
|
bordetella pertussis
|
|
what is mechanism of pertussis toxin?
|
increased levels of intracellular cAMP
|
|
who is most susceptible to bordetella infection?
|
newborn
|
|
what is vaccine for bordetella and what are recommendations?
|
DTaP (purified F-HA, PT toxoid) with Tdap booster every five years
|
|
morphology of strep. pneumoniae?
|
Gm(+) lancet shaped diplococci
|
|
major virulence factor for strep. pneumoniae?
|
capsule
|
|
what is most common cause of meningitis in adults?
|
pneumococcus
|
|
most common cause of otitis media?
|
pneumococcus
|
|
diagnosis of pneumococcus?
|
urine antigen test
|
|
vaccine for pneumococcus?
|
PPV purified polysaccharide and PCV7 conjugated vaccine
|
|
what are two problems with the emerging pathogen acinetobacter baumannii?
|
antibiotic resistance and nosocomial in US hospitals
|
|
distinctive about pseudomonas capsule?
|
slime or mucoid [CF]
|
|
clinical manifestations of pseudomonas?
|
nosocomial pneumonia, cystic fibrosis pneumonia, burn or wound infections (green pus), UTI (catheter), dermatitis (more severe risk in diabetics), corneal infections, endocarditis
|
|
what is recommended treatment for pseudomonas-family infection?
|
combination, resistant to many antibiotics
|
|
where does legionella grow in human body?
|
intracellularly in macrophages
|
|
clinical manifestations with legionella?
|
legionnaires disease [acute pneumonia] or pontiac fever [mild respiratory, no pneumonia]
|
|
diagnosis for legionella?
|
urine antigen test, only for serogroup 1
|
|
what is cell wall of mycobacteria composed of?
|
glycolipids containing mycolic acids
|
|
morphology of aspergillus?
|
only as a filamentous mold with septate hyphae and 45 degree branching
|
|
clinical manifestations of aspergillus?
|
allergic (upper respiratory allergies, hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis), localized infections (aspergilloma, chronic necrotizing aspergillus pneumonia, aspergillus sinusitis, otomycosis), invasive aspergillosis (lung or bloodstream)
|
|
treatment of choice for aspergillus?
|
voriconazole - quickly
|
|
morphology of zygomycetes?
|
large diameter non-septate hyphae with 90 degree branching, do not grow well at 37 C
|
|
clinical manifestations of zygomycetes (mucormycosis)?
|
rhinocerebral (uncontrolled diabetics susceptible), pulmonary, disseminated, cutaneous, gi
|
|
distinguishing features of blastomyces?
|
broad based budding and may present as cutaneous
|
|
distinguishing features of coccidiodes?
|
spherule with meningitis most serious and lethal complication
|
|
most common endemic fungal infection?
|
histoplasma
|
|
diagnosis of histoplasmosis?
|
antigen detection
|
|
morphology of clostridium?
|
large Gm(+) sporeforming rods, obligate anaerobes
|
|
most potent bacterial toxin and mechanism?
|
botulinum; prevents release of Ach at neuromuscular junction
|
|
clinical manifestations and identify the most common?
|
food-borne [18-36 hrs, symmetric descending flaccid paralysis], wound, infant [most common, 2wks -6 mos later, honey]
|
|
diagnosis and treatment for botulism?
|
cranial nerve involvement, administer polyvalent A, B, E antitoxin, supportive respiratory care
|
|
why can a vaccine be formulated against tetanus and what is the toxin mechanism?
|
one serotype; travels retrograde intra-axonally to block release of glycine at inhibitory synapse
|
|
vaccine and management for tetanus?
|
passive immunization with antitoxin; DTaP and Tdap [need booster to maintain circulating antibody levels]
|
|
morphology of neisseria?
|
Gm(-) diplococci
|
|
major virulence factor in meningococcus?
|
capsule
|
|
clinical manifestations of meningococcus?
|
local infection, meningococcemia [endotoxin shock, DIC --> amputations], meningitis [permanent CNS damage]; extremely rapid progression [24 hrs]
|
|
vaccine for meningococcus and shortcomings?
|
MPSV4 for >55; MCV4 conjugated; serogroup B capsule is not effective in any vaccine yet
|
|
clinical manifestations of cryptococcus?
|
pulmonary [not always symptomatic], CNS cryptococcosis, disseminated
|
|
diagnosis of cryptococcus?
|
CSF examination for cryptococcal antigen or with india ink
|